AIMOVIG, also known by its generic name erenumab, is a cutting-edge prescription medication specifically designed for the preventive treatment of migraine in adults. It belongs to a class of drugs known as calcitonin gene-related peptide (CGRP) receptor antagonists. CGRP is a molecule involved in migraine attacks, and by targeting and blocking its receptor, AIMOVIG helps to reduce the frequency, duration, and severity of migraine episodes. This medication is administered through a subcutaneous injection, typically once a month, and is noted for its ability to significantly improve the quality of life for those suffering from chronic and episodic migraines. As with any medication, it is important to consult a healthcare provider to determine if AIMOVIG is the right treatment option, considering its benefits and potential side effects.
When using Aimovig, a prescription medication designed to prevent migraines, it's crucial to adhere strictly to your doctor's instructions and thoroughly read the label that accompanies the medicine. Aimovig can cause side effects, with the most common ones being injection site reactions (such as pain, redness, or swelling) and constipation. Although rare, some individuals may experience more serious side effects, including allergic reactions. It's important to report any unusual symptoms to your healthcare provider immediately. While Aimovig is not known to directly impair your ability to drive or operate machinery, experiencing a migraine attack or certain side effects could potentially make these activities unsafe. Additionally, always inform your doctor about all other medications you are taking, including over-the-counter drugs and supplements, to avoid potential drug interactions. Following these precautions can help ensure your treatment is both safe and effective.